No Data
No Data
A total scale of 30 billion! The first national-level mother fund in the foreign trade and economic field is being raised, introducing listed company LP Jinbo Bio and Joinn Laboratories.
① The Innovation and Development Guidance Fund for Service Trade is a national-level fund initiated by the Ministry of Finance, the Ministry of Commerce, and China Merchants Group, approved by the State Council, with a total scale of 30 billion yuan. ② An IR practitioner stated to the Star Daily that the second phase of the service trade fund inviting listed companies to become LPs may be a more market-oriented signal.
Joinn Laboratories (06127.HK) spent 0.885 million yuan on December 13 to repurchase 0.05 million shares.
On December 13, Gelonghui reported that Joinn Laboratories (06127.HK) announced that on December 13, 2024, the company spent 0.885 million yuan to repurchase 0.05 million shares on the Shanghai Stock Exchange, with a repurchase price of 17.7 yuan per share.
The U.S. bioterrorism law has undergone significant changes, the CRO concept has launched a major counterattack, and WuXi AppTec is excited!
Industry pessimistic expectations may improve.
Honkong stock market movement | CRO concept stocks collectively opened higher as the bioprotective legislation was not included in the final version of the NDAA by the U.S. Senate and House of Representatives.
CRO concept stocks opened higher collectively. As of the time of writing, wuxi bio (02269) increased by 13.03%, trading at 19.6 Hong Kong dollars; wuxi apptec (02359) rose by 11.72%, trading at 61 Hong Kong dollars; pharmaron (03759) climbed by 9.14%, trading at 16 Hong Kong dollars.
How to break through the challenges in the development of innovative drugs? The industry suggests focusing on internationalization.
① The year 2024 will be the inaugural year of large-scale authorized trade, and going abroad has become an important direction for the development of local pharmaceutical companies; ② Chinese企业品牌, clinical trial capabilities, data presentation formats, and levels of international operation still need time and practical verification.
Hong Kong stocks unusual movement | CRO concept stocks expanded their gains, wuxi apptec (02359) surged 12% at one point. It is rumored that US legislators are considering making changes to the bioterrorism law.
CRO concept stocks further expanded their gains. As of the time of publication, wuxi apptec (02359) rose by 10%, trading at 55 Hong Kong dollars; pharmaron (03759) increased by 8.12%, trading at 14.64 Hong Kong dollars; wuxi bio (02269) went up by 7.02%, trading at 17.6 Hong Kong dollars.
No Data